Syschem (India) has secured its board’s approval for expansion of its existing plant units. The expansion includes the addition of a new manufacturing unit for Amoxicillin and Ampicillin, along with further expansion of the existing CDF unit comprising Cloxacillin Sodium, Dicloxacillin Sodium, and Flucloxacillin Sodium. Additionally, the company will expand its Effluent Treatment Plant (ETP) and Multi-Effect Evaporator (MEE) to strengthen environmental compliance and support sustainable operations.
This expansion is expected to significantly enhance the company’s manufacturing capacity, operational efficiency, and environmental management capabilities. The estimated investment required for the expansion is around Rs 14 crore and the expanded capacities are expected to be commissioned by December, 2026.
Syschem (India) is engaged in manufacturing pesticides' namely Monocrotophos (MCP) and Dichlorvos (DDVP).
